职业棒球运动员结局报告的系统综述:呼吁提高验证性与一致性
该系统综述纳入54项研究,评估职业棒球运动员治疗疗效的报告方式,发现51项(94%)报告重返赛场(RTP),12项(22%)使用功能结局评分,18项(33%)提供棒球特异性表现统计数据;随访定义、时长和所用表现统计指标差异很大,且无研究对这些表现统计指标进行验证、确定所需最短随访时间或评估未受伤球员的基线变异。作者认为需额外研究来验证这些指标并确定适当随访时长。
要点
- 54项研究中51项(94%)以重返赛场率评估疗效,仅18项(33%)报告棒球特异性表现统计。
- 随访定义(比赛、赛季、月)、随访时长及所用表现统计指标均存在很大差异。
- 无研究验证表现统计指标、确定最短随访时间或评估未受伤球员的基线变异。
核心结论
- 多数研究以重返赛场率确定治疗疗效,但球员随访方式存在显著差异。
- 所用表现统计指标的类型和数量也存在很大差异。
- 需要额外研究来验证这些指标并确定应随访的适当时长。
研究设计与样本
- 系统综述,检索PubMed、Embase和Cochrane数据库中所有报告职业棒球治疗疗效的研究。
- 共纳入54项符合全部纳入标准的研究。
主要发现
- 51项研究(94%)报告重返赛场,12项(22%)使用功能结局评分,18项(33%)提供棒球特异性表现统计数据以评估治疗疗效。
- 随访定义(比赛、赛季、月)、随访时长以及所用表现统计指标存在很大差异。
- 无研究验证这些表现统计指标、确定所需最短随访时间或评估未受伤球员中这些统计指标的基线变异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要额外研究来验证这些指标并确定应随访的适当时长。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Historically, treatment efficacy of professional baseball injuries has been determined by assessing the return-to-play (RTP) rate or using patient-reported functional outcomes scores; however, these methods may not be sensitive and specific enough for elite athletes. As a consequence, performance-based statistics are increasingly being reported in the medical literature. PURPOSE: To (1) assess how treatment efficacy is currently reported in professional baseball players; (2) examine the variability in the reporting of these measures in terms of frequency, length of time followed, and units of measure; and (3) identify any attempts to validate these performance-based statistics. STUDY DESIGN: Systematic review. METHODS: All studies reporting treatment efficacy in professional baseball in PubMed, Embase, and Cochrane were identified. Data collected included frequency and method of reporting: RTP, functional outcomes, and performance-based statistics. RESULTS: Fifty-four studies met all inclusion criteria. Of these, 51 (94%) reported RTP, 12 (22%) utilized functional outcomes, and 18 (33%) provided baseball-specific performance-based statistics to assess treatment efficacy. Great variability was seen in how follow-up was defined (games, seasons, months), duration of follow-up, and which performance-based statistics were utilized. None of the studies validated these performance-based statistics, determined minimal time of follow-up needed, or assessed the baseline variability in these statistics among noninjured players. CONCLUSION: Most studies reported RTP to determine treatment efficacy, but significant variability was seen in how players were followed. Similarly, great variability was noted in the type and number of performance-based statistics utilized. Additional studies are necessary to validate these measures and determine the appropriate length of time that they should be followed. CLINICAL RELEVANCE: This study provides a clear overview of the current methods that are used to determine treatment efficacy in professional baseball players.
引用
- van der List JP, Camp CL, Sinatro AL, et al. Systematic Review of Outcomes Reporting in Professional Baseball: A Call for Increased Validation and Consistency. Am J Sports Med. 2017. PMID: 28355083. doi:10.1177/0363546517697690
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。